Boston Pharma signs out-licensing agreement with GSK
Boston Pharmaceuticals and GlaxoSmithKline (GSK) have entered into a three-year out-license and option agreement to advance multiple pre-phase two programmes.…
Boston Pharmaceuticals and GlaxoSmithKline (GSK) have entered into a three-year out-license and option agreement to advance multiple pre-phase two programmes.…
Anima Biotech and Takeda Pharmaceutical are collaborating to discover and develop mRNA translation modulators for neurological diseases. According to the…
Hoth Therapeutics and the University of Cincinnati Research Institute (UCRI) in the US have signed a research agreement to conduct…
Merck is adding a €25m, single-use assembly production unit at its Life Science Center (LSC) in Molsheim, France, to manufacture…
Indian pharmaceutical company Gland Pharma has signed an agreement with the Russian Direct Investment Fund (RDIF) for the manufacture of…
AstraZeneca (AZ) has signed an agreement with the US Department of Health and Human Services (HHS) and the Department of…
Aurinia Pharmaceuticals (IPHAF) has announced a positive cost-effectiveness assessment of LUPKYNIS (voclosporin) based on the Institute for Clinical and Economic…
Novartis has unveiled positive data from two studies of new gene therapy Zolgensma, which demonstrated that children with spinal muscular…
US-based company W R Grace is set to expand its pharma portfolio with the acquisition of Albemarle’ Fine Chemistry Services…
Merck has agreed to acquire biotechnology company Pandion Therapeutics for approximately $1.85bn to expand its portfolio of autoimmune disease-targeting candidates.…